Clinical Trial Update: A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients [Phase 1]

View source ↗

Summary

A Phase I study evaluating intravenous aflibercept in combination with S-1 in Japanese cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Aflibercept (Aflibercept)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms | Phase 1 | Status: COMPLETED